Netflix
NFLX
Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
INM InMed Pharmaceuticals
- 4.0000
- -1.0500-20.79%
Close Jan 22 16:00 ET
- 4.0300
- +0.0300+0.75%
Pre 05:07 ET
2.90MMarket Cap-0.52P/E (TTM)
4.7500High3.9600Low644.82KVolume4.4500Open5.0500Pre Close2.86MTurnover106.95%Turnover RatioLossP/E (Static)724.15KShares15.696052wk High0.35P/B2.41MFloat Cap2.414052wk Low--Dividend TTM602.92KShs Float3210.0000Historical High--Div YieldTTM15.64%Amplitude2.4000Historical Low4.4390Avg Price1Lot Size
About InMed Pharmaceuticals Company
InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around the research and development of small molecule pharmaceuticals drug candidates. The BayMedica segment focuses on the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Company Profile
SymbolINM
Company NameInMed Pharmaceuticals
Issue Price4.50
Founded1981
CEOMr. Eric A. Adams
MarketNASDAQ
Employees13
Fiscal Year Ends06-30
Address885 West Georgia Street,Suite 1445
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6C 3E8
Phone1-604-669-7207
Websitehttp://www.inmedpharma.com
Company Executives
- Name
- Position
- Salary
- Eric A. Adams
- Director, President and Chief Executive Officer
- 367.57K
- Michael Woudenberg
- Chief Operating Officer
- 297.42K
- N. Netta Jagpal
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Eric C. Hsu, PhD
- Senior Vice President, Preclinical Research and Development
- --
- Andrew Hull
- Chairman of the Board
- 61.10K
- Nicole Lemerond
- Independent Director
- 46.21K
- Bryan T. Baldasare
- Independent Director
- 48.60K
- Jonathan Tegge
- Corporate Controller
- --
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.